Abstract
The new coronavirus (known as COVID-19) was first identified in Wuhan and quickly spread worldwide, wreaking havoc on the economy and people’s everyday lives. Fever, cough, sore throat, headache, exhaustion, muscular aches, and difficulty breathing are all typical symptoms of COVID-19. A reliable detection technique is needed to identify affected individuals and care for them in the early stages of COVID-19 and reduce the virus’s transmission. The most accessible method for COVID-19 identification is RT-PCR; however, due to its time commitment and false-negative results, alternative options must be sought. Indeed, compared to RT-PCR, chest CT scans and chest X-ray images provide superior results. Because of the scarcity and high cost of CT scan equipment, X-ray images are preferable for screening. In this paper, a pre-trained network, DenseNet169, was employed to extract features from X-ray images. Features were chosen by a feature selection method (ANOVA) to reduce computations and time complexity while overcoming the curse of dimensionality to improve predictive accuracy. Finally, selected features were classified by XGBoost. The ChestX-ray8 dataset, which was employed to train and evaluate the proposed method. This method reached 98.72% accuracy for two-class classification (COVID-19, healthy) and 92% accuracy for three-class classification (COVID-19, healthy, pneumonia).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involves only openly available ChestX-ray8 dataset, which can be obtained from https://github.com/seyyedalialavi2000/COVID-19-detection
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Publicly available ChestX-ray8 dataset was used in this study, which is available at https://github.com/seyyedalialavi2000/COVID-19-detection
The source code of the proposed method required to reproduce the predictions and results is available at https://github.com/seyyedalialavi2000/COVID-19-detection
